Compare AMBALAL SARABHAI with SEQUENT SCIENTIFIC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMBALAL SARABHAI vs SEQUENT SCIENTIFIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMBALAL SARABHAI SEQUENT SCIENTIFIC AMBALAL SARABHAI/
SEQUENT SCIENTIFIC
 
P/E (TTM) x 6.0 54.7 11.0% View Chart
P/BV x 3.8 6.1 62.7% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 AMBALAL SARABHAI   SEQUENT SCIENTIFIC
EQUITY SHARE DATA
    AMBALAL SARABHAI
Mar-21
SEQUENT SCIENTIFIC
Mar-21
AMBALAL SARABHAI/
SEQUENT SCIENTIFIC
5-Yr Chart
Click to enlarge
High Rs31265 11.7%   
Low Rs1570 21.3%   
Sales per share (Unadj.) Rs21.454.8 39.0%  
Earnings per share (Unadj.) Rs2.64.2 62.8%  
Cash flow per share (Unadj.) Rs3.06.2 47.4%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Avg Dividend yield %00.3 0.0%  
Book value per share (Unadj.) Rs9.629.0 33.3%  
Shares outstanding (eoy) m76.63248.37 30.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.13.1 35.1%   
Avg P/E ratio x8.739.8 21.8%  
P/CF ratio (eoy) x7.826.8 28.9%  
Price / Book Value ratio x2.45.8 41.2%  
Dividend payout %011.9 0.0%   
Avg Mkt Cap Rs m1,75741,590 4.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2821,872 15.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,63613,616 12.0%  
Other income Rs m30684 365.6%   
Total revenues Rs m1,94213,700 14.2%   
Gross profit Rs m-152,032 -0.8%  
Depreciation Rs m24506 4.8%   
Interest Rs m32244 13.1%   
Profit before tax Rs m2341,366 17.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m32322 9.9%   
Profit after tax Rs m2021,045 19.4%  
Gross profit margin %-0.914.9 -6.3%  
Effective tax rate %13.623.6 57.8%   
Net profit margin %12.47.7 161.2%  
BALANCE SHEET DATA
Current assets Rs m1,2067,667 15.7%   
Current liabilities Rs m1,2855,140 25.0%   
Net working cap to sales %-4.918.6 -26.2%  
Current ratio x0.91.5 62.9%  
Inventory Days Days6631 212.9%  
Debtors Days Days86693 933.0%  
Net fixed assets Rs m8726,763 12.9%   
Share capital Rs m766497 154.3%   
"Free" reserves Rs m-276,702 -0.4%   
Net worth Rs m7397,199 10.3%   
Long term debt Rs m52937 5.5%   
Total assets Rs m2,07814,430 14.4%  
Interest coverage x8.36.6 126.1%   
Debt to equity ratio x0.10.1 53.8%  
Sales to assets ratio x0.80.9 83.5%   
Return on assets %11.38.9 126.4%  
Return on equity %27.414.5 188.8%  
Return on capital %33.719.8 170.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m0686 0.0%   
Fx outflow Rs m0281 0.0%   
Net fx Rs m0405 -0.0%   
CASH FLOW
From Operations Rs m-231,148 -2.0%  
From Investments Rs m10196 104.6%  
From Financial Activity Rs m-58-1,388 4.2%  
Net Cashflow Rs m20-144 -13.6%  

Share Holding

Indian Promoters % 30.8 0.0 -  
Foreign collaborators % 0.0 53.0 -  
Indian inst/Mut Fund % 0.0 8.6 0.1%  
FIIs % 0.0 6.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 69.2 47.0 147.4%  
Shareholders   182,946 167,812 109.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMBALAL SARABHAI With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Nazara Tech's Acquisition in Ad Tech Company, boAt-Dixon Technologies form JV, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a weak note yesterday. Benchmark indices witnessed heavy selling in the fag-end of the session as weak global cues.

Related Views on News

SEQUENT SCIENTIFIC 2020-21 Annual Report Analysis (Annual Result Update)

Oct 25, 2021 | Updated on Oct 25, 2021

Here's an analysis of the annual report of SEQUENT SCIENTIFIC for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SEQUENT SCIENTIFIC. Also includes updates on the valuation of SEQUENT SCIENTIFIC.

SEQUENT SCIENTIFIC Announces Quarterly Results (1QFY22); Net Profit Down 86.3% (Quarterly Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

For the quarter ended June 2021, SEQUENT SCIENTIFIC has posted a net profit of Rs 26 m (down 86.3% YoY). Sales on the other hand came in at Rs 3 bn (up 8.6% YoY). Read on for a complete analysis of SEQUENT SCIENTIFIC's quarterly results.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMBALAL SARABHAI SHARE PRICE


Jan 18, 2022 (Close)

TRACK AMBALAL SARABHAI

  • Track your investment in AMBALAL SARABHAI with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AMBALAL SARABHAI

AMBALAL SARABHAI 8-QTR ANALYSIS

COMPARE AMBALAL SARABHAI WITH

MARKET STATS